BioCentury | Feb 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: January 2018

...pain. University of Illinois Distillery Therapeutics Cancer Acute myelogenous leukemia (AML); chronic myelogenous leukemia (CML) Protein promyelocytic leukemia...
BioCentury | Jan 23, 2018
Distillery Therapeutics

Cancer

...steps could include identifying and testing PML inhibitors in models of CML and AML. TARGET/MARKER/PATHWAY: Protein promyelocytic leukemia...
...Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. email: ppandolf@bidmc.harvard.edu Hongjiang Li Beth Israel Deaconess Medical Center Protein promyelocytic leukemia...
Items per page:
1 - 2 of 2